Business Information
The group's principal activity is to develop and sell instruments and associated consumables to pharmaceutical companies. The group's generates large chemical compounds for drug discovery and provides instrumentation to generate compound libraries. The other services provided by the group include, drug discovery products and services to pharmaceutical and biotechnology companies. The group's main product includes assays, compound libraries, including combinatorial chemistry instruments, parallel synthesis, split-and-pool synthesis. The group's major customers are pfizer, merck, novartis, inspire pharmaceuticals and glaxosmithkline. The trademarks of the group include irori(R), microkan(R), synthesis manager(R), clevap(R), nanokan(R) and xenometrix(r).
|
|
Name |
Title
|
Email
|
| Steven Holtzman | Chmn., CEO | N/A | | Julian Adams | Pres., Chief Scientific Officer | N/A | | Adelene Perkins | Exec. VP, Chief Business Officer | N/A | | Anthony Evnin | Dir. | N/A | | Arnold Levine | Dir. | N/A |
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
